Every woman dreams of a set of thick, fluttery eyelashes to bat at unsuspecting handsome men. While fake lash strips and individual flares can get the job done, applying them is overly laborious for a daily basis. Latisse was introduced in 2009 as the first prescription treatment for “not enough lashes,” as the advertisements say, and has remained the top contender in lash growth products since. But Latisse isn’t exactly accessible: a doctor’s appointment is required, which tags on to the already high price of the prescription product. It looks as though Latisse may have some serious competition over at Obagi, the makers of professional-strength skincare products. Obagi’s Elastilash targets many of Latisse’s downfalls, creating a product that women may just be clamoring to get their hands on.
The Lowdown on Latisse
Latisse is produced by Allergan, the pharmaceutical giant responsible for Botox, Natrelle breast implants, Juvederm, and other important cosmetic materials. Latisse’s main ingredient is bimatoprost, a chemical compound originally developed to treat glaucoma. But when glaucoma sufferers noticed that their medication was also giving them long, lush lashes, Allergan coined Latisse as a prescription cosmetic. The product puts lashes into the anagen (hair growth) phase, as well as encouraging melanin (pigment) development. In order to get your hands on Latisse, you’ll have to schedule an appointment with a doctor. A one-month supply of Latisse runs in at about $120, and you can expect to pay full price. Insurance companies won’t consider hypertrichosis, or not enough lashes, as a medical condition.
Latisse isn’t for everyone. Aside from its high price tag (product price coupled with the potential cost of a doctor visit), Latisse is known to have some interesting side effects. People with light eyes have noticed that using Latisse can permanently darken their iris to brown, even after they stop using the product. The same goes with the lash line—the melanin can cause the skin to become darker permanently. Other side effects include lash fallout, eye redness, and itching.
Latisse vs Obagi Elastilash
Obagi Elastilash is a non-prescription lash enhancement product that works a little bit differently than Latisse. Unlike Latisse, Elastilash coats and enhances existing eyelashes using peptides. Obagi does not claim that Elastilash will grow your lashes or make them truly thicker; but it condition and strengthen what’s already there. If Latisse is like Rogaine for the lashes, then Elastilash is just a really high-grade conditioner.
Elastilash appears to be targeting Latisse deferrals by specifically noting that their product is ideal for people with light skin and light eyes. Since there are no melanin-encouraging chemicals in the product, there’s no risk for hyperpigmentation.
Elastilash also appears to work a little bit faster than the infamously slow Latisse, which can take up to a few months to really kick in. Elastilash should show results in about 4-6 weeks. And at $60 a pop, it’s a little bit more reasonable than Latisse.
Bottom line: Elastilash isn’t going to kick Latisse out of its top spot anytime soon. Latisse is one of the only products that truly grows more eyelashes, creating a noticeable difference in the appearance of one’s eyes. Elastilash is only a better choice for two types of people: those with light skin and eyes concerned with melanin darkening, and those who just want a slight boost in their lashes.
New Image Specialists can book you a personal consultation with a Latisse provider. find a doctor in your area now!